Sangamo BioSciences

Sangamo's Phase II Results To Be Announced Monday - Expect Good News
Seeking Alpha
Sun, 10/2/11 - 12:28 pm
Sangamo BioSciences
SB-509
diabetic neuropathy
Sangamo BioSciences to Host Conference Call to Discuss Results From Phase 2b Trial of SB-509 in Diabetic Neuropathy
Yahoo/PR NewsWire
Sat, 10/1/11 - 01:47 pm
Sangamo BioSciences
diabetic neuropathy
SB-509
Are HIV Drugmakers Doomed?
Motley Fool
Fri, 09/30/11 - 09:25 am
HIV
Pfizer
Merck
JNJ
Bristol-Myers Squibb
Sangamo BioSciences
Gilead
Abbott Laboratories
The Wisdom Of The Crowds And Sangamo's Phase II B Clinical Trial Results
Seeking Alpha
Wed, 09/28/11 - 09:17 am
Sangamo BioSciences
SB-509
diabetic neuropathy
The Next Big Thing in Biotech: Sangamo (video)
The Street
Sun, 09/18/11 - 12:11 pm
Sangamo BioSciences
[video] The Next Big Thing In Biotech: Sangamo
TheStreet.com
Fri, 09/16/11 - 12:10 pm
Sangamo BioSciences
HIV
Sangamo: An Introduction to Its Gene Altering Technology
Seeking Alpha
Thu, 08/4/11 - 10:19 am
Sangamo BioSciences
Merck, Sangamo to Gain From $70 Million Boost in AIDS Cure Hunt
Bloomberg
Mon, 07/11/11 - 12:17 pm
AIDS
HIV
Merck
Sangamo BioSciences
grants
10 Biotech Trades for Second Half of 2011
TheStreet.com
Wed, 07/6/11 - 08:51 am
Sangamo BioSciences
BioSante
Seattle Genetics
YM BioSciences
Exelixis
Transcept
Oncothyreon
Gilead Sciences
Medivation
Neoprobe
Sangamo's Inevitable Acquisition/Merger
Seeking Alpha
Sun, 05/22/11 - 04:59 pm
Sangamo BioSciences
HIV
Sangamo Biosciences's Game Changing Technology
Seeking Alpha
Wed, 04/20/11 - 09:57 am
Sangamo BioSciences
ZFP technology
Sangamo BioSciences to raise $51M in stock offering Read more: Sangamo BioSciences to raise $51M in stock offering | San Francisco Business Times
bizjournals.com
Sat, 04/9/11 - 10:53 am
Sangamo BioSciences
diabetic neuropathy
DPP HIV
hemophilia
brain cancer
Sangamo: The Next Pinnacle in HIV Treatment?
Seeking Alpha
Tue, 03/8/11 - 11:45 am
Sangamo BioSciences
HIV
Sangamo shares in biotech spotlight
MarketWatch
Sat, 02/26/11 - 10:04 am
Sangamo BioSciences
SB-728
HIV
Sangamo shares in biotech spotlight
Marketwatch
Fri, 02/25/11 - 03:44 pm
Sangamo BioSciences
HIV
Biotech Busts And Breakthroughs In December
Forbes
Mon, 01/3/11 - 02:44 pm
biotech
InterMune
Orexigen
Exelixis
Dynavax
Sangamo BioSciences
Pain Therapeutics
Abiomed
Keryx
Geron
Clinical Data
15 Biotech Stocks With the Lowest Put/Call Ratios
Seeking Alpha
Wed, 10/13/10 - 12:09 pm
biotech
Anadys
BioSante
Cerus
CompuGen
Cytokinetics
Cell Therapeutics
Idera Pharmaceuticals
Medivation
MDRA
RXi Pharmaceuticals
Sangamo BioSciences
Talecris
3SBio
Vical
Trimeris
7 Firms Developing RNAi Drugs
TheStreet.com
Tue, 03/30/10 - 09:53 am
RNAi
Isis Pharmaceuticals
Merck
MRNA
Alnylam
RXi Pharmaceuticals
Sangamo BioSciences
Tekmira Pharmaceuticals
Sangamo Says Experimental Therapy Kept HIV Level Low in Patient
Bloomberg
Tue, 01/19/10 - 09:29 am
HIV
Sangamo BioSciences
Stocks to Watch at Biotech’s Bellwether Conference
Minyanville
Mon, 01/11/10 - 09:28 pm
Medtronic
Gilead Sciences
Human Genome
Novartis
GSK
Sangamo BioSciences
Indenix

Pages